|1.||Kardos, Gregory R: 1 article (10/2015)|
|2.||Robertson, Gavin P: 1 article (10/2015)|
|3.||Wastyk, Hannah C: 1 article (10/2015)|
|4.||Reversade, Bruno: 1 article (09/2015)|
|5.||Lin, Angela E: 1 article (09/2015)|
|6.||Pivnick, Eniko K: 1 article (09/2015)|
|7.||Meierhofer, David: 1 article (09/2015)|
|8.||Al Bughaili, Mohammed: 1 article (09/2015)|
|9.||Ganesh, Jaya: 1 article (09/2015)|
|10.||Fischer-Zirnsak, Björn: 1 article (09/2015)|
09/01/1981 - "Cells from patients with a rare ocular disease, gyrate atrophy of the choroid and retina, were used for these studies since they lack interfering ornithine aminotransferase activity. "
12/01/2001 - "Gyrate atrophy of the choroid and retina is a chorioretinal degeneration caused by a deficiency of ornithine aminotransferase. "
07/01/1996 - "To identify mutations in ornithine aminotransferase (OAT) in seven Japanese families with gyrate atrophy (GA), an autosomal recessive chorioretinal degeneration of the eye caused by a generalized biochemical deficiency in OAT; mutations in the OAT gene have shown a high degree of molecular heterogeneity. "
07/01/1996 - "Heterogeneity and uniqueness of ornithine aminotransferase mutations found in Japanese gyrate atrophy patients."
03/01/1994 - "A generalized biochemical deficiency of the mitochondrial matrix enzyme ornithine aminotransferase (OAT) is the inborn error in gyrate atrophy (GA), an autosomal recessive blinding disease of the retina and choroid of the eye. "
09/01/2012 - "It has been proven that ornithine aminotransferase (OAT) might play an important role in the oncogenesis and progression of numerous malignant tumors. "
10/01/1987 - "Ornithine aminotransferase turnover in host tissues of tumor-bearing rats."
01/01/1987 - "Ornithine aminotransferase (OAT) activity was decreased in TS, especially in TS (tumor) after mild sonication treatment. "
10/01/2015 - "Inhibition of ALDH18A1, the gene encoding pyrroline-5-carboxylate synthase (P5CS), significantly decreased cultured melanoma cell viability and tumor growth. "
01/01/1988 - "Presence of an extrahepatic neoplasm as well as administration of clofibrate resulted in marked decrease in activities of hepatic arginase and ornithine transaminase. "
|3.||Hepatocellular Carcinoma (Hepatoma)
08/13/2015 - "Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase."
05/22/1977 - "Expression mechanism of abnormality of ornithine aminotransferase level in Morris hepatomas."
11/01/1976 - "These results show that the high ornithine aminotransferase content of hepatoma 44 is due to both increase in its rate of synthesis and decrease in its rate of degradation."
11/01/1976 - "The rate constant of degradation of ornithine aminotransferase in hepatoma 44 was significantly less than that in host liver. "
11/01/1976 - "The half-life of ornithine aminotransferase in host liver was 0.98 day, which was the same as that in normal liver, whereas that in hepatoma 44 was 3.5 days. "
|4.||Synovial Sarcoma (Synovioma)
06/01/1993 - "In a previous study we localized the synovial sarcoma-associated t(X;18)(p11;q11) breakpoint within the ornithine aminotransferase-like 1 (OATL1) cluster on the X chromosome. "
04/01/1994 - "In spite of these complex chromosomal rearrangements, the Xp11 breakpoint could be mapped to within the ornithine aminotransferase (OAT)L1 cluster, very similar to that reported previously for the standard t(X;18)(p11;q11) in synovial sarcomas. "
04/01/1994 - "A synovial sarcoma with a complex t(X;18;5;4) and a break in the ornithine aminotransferase (OAT)L1 cluster on Xp11.2."
04/01/1994 - "Fluorescence in situ hybridization (FISH) and molecular analyses of synovial sarcomas with cytogenetically similar (X;18)(p11.2;q11.2) translocations have revealed two alternative breakpoint regions in Xp11.2, one residing in the ornithine aminotransferase-like 1 (OATL1) region and the other one in the related but distinct OATL2 region. "
12/01/1993 - "We used fluorescence in situ hybridization (FISH) and somatic cell hybridization techniques to demonstrate 1) that the Xp11 translocation breakpoint in papillary renal cell carcinoma differs from that observed in synovial sarcoma and has a more proximal location, and 2) that an ornithine aminotransferase (OAT)L2 containing yeast artificial chromosome (YAC) spans the X;1 translocation. "
|5.||Experimental Liver Neoplasms
|2.||Vitamin B 6
|3.||Pyridoxal Phosphate (Pyridoxal 5 Phosphate)
|7.||Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)
|8.||Ornithine Decarboxylase (Decarboxylase, Ornithine)
|9.||Complementary DNA (cDNA)